Senti Biosciences, Inc.
Data quality: 100%
SNTI
Nasdaq
Manufacturing
Chemicals
$0.86
▲
$0.01
(1.04%)
Mkt Cap: 26.82 M
Price
$0.86
Mkt Cap
26.82 M
Day Range
$0.84 — $0.89
52-Week Range
$0.77 — $5.10
Volume
88,432
Open $0.87
50D / 200D Avg
$0.93
6.97% below
50D / 200D Avg
$1.49
42.32% below
Quick Summary
Key Takeaways
Negative free cash flow of -43.64 M
Capital intensive — 890.91% of revenue goes to capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-374.93%
Below sector avg (-53.41%)
ROIC-109.54%
Net Margin-279263.64%
Op. Margin-312631.82%
Safety
Debt / Equity
N/A
Current Ratio1.51
Interest CoverageN/A
Valuation
PE (TTM)
-0.44
Above sector avg (-1.48)
P/B Ratio3.30
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.4 | -1.5 |
| P/B | 3.3 | 1.6 |
| ROE % | -374.9 | -53.4 |
| Net Margin % | -279263.6 | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | -90.73% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 22,000.0 | Net Income (TTM) | -61.44 M |
| ROE | -374.93% | ROA | -101.36% |
| Gross Margin | N/A | Operating Margin | -312631.82% |
| Net Margin | -279263.64% | Free Cash Flow (TTM) | -43.64 M |
| ROIC | -109.54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.51 |
| Interest Coverage | N/A | Asset Turnover | 0.00 |
| Working Capital | 6.13 M | Tangible Book Value | 8.12 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.44 | Forward P/E | N/A |
| P/B Ratio | 3.30 | P/S Ratio | 1218.88 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -162.74% | ||
| Market Cap | 26.82 M | Enterprise Value | 14.57 M |
| Per Share | |||
| EPS (Diluted TTM) | -2.73 | Revenue / Share | 0.00 |
| FCF / Share | -1.40 | OCF / Share | -1.39 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 890.91% | FCF Conversion | 71.03% |
| SBC-Adj. FCF | -48.59 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 22,000.0 | 0.0 | 2.56 M | — | 4.29 M |
| Net Income | -61.44 M | -52.79 M | -71.06 M | -3.86 M | -58.21 M |
| EPS (Diluted) | -2.73 | -12.03 | -1.60 | — | -2.23 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -68.78 M | -61.04 M | -92.73 M | -3.87 M | -70.63 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 37.59 M | 34.36 M | 32.15 M | — | 34.07 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0.0 | — | — | 0.0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 51.22 M | 97.84 M | 119.48 M | 231.46 M | 180.79 M |
| Total Liabilities | 45.63 M | 47.09 M | 52.57 M | 10.33 M | 53.53 M |
| Shareholders' Equity | 5.59 M | 25.65 M | 66.91 M | -8.88 M | 127.26 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 16.42 M | 48.28 M | 35.93 M | 889,323.0 | 57.62 M |
| Current Assets | 23.27 M | 58.96 M | 71.20 M | 1.30 M | 102.58 M |
| Current Liabilities | 13.97 M | 13.15 M | 12.67 M | 3.28 M | 18.05 M |
{"event":"ticker_viewed","properties":{"ticker":"SNTI","listing_kind":"stock","pathname":"/stocks/snti","exchange":"Nasdaq","country":"US"}}